PubMed · 12378139
[Methodologies used to screen for doping agents].
Abstract
The detection of doping agents is a major challenge due both to the large number of compounds involved, their structural diversity, and to the sensitivity thresholds required in a small volume of urine. In addition, laboratories are requested to delivery their reports within a short delay. Mass spectrometry "ion trap" and "high-resolution" methods can be used to screen for xenobiotics at the required sensitivity levels. The search for endogenous substances used as doping agents is more complex: here the difference between physiological production and exogenous input must be recognized. Isotopic mass spectrometry appears to provide a means of resolving this problem for compounds with a low molecular mass such as steroids. Search for peptide hormones is limited to erythropoietin, with the exception of quantification procedures for human gonadotropin chorionic hormone. Direct urine screening is however a long costly operation which does not always produce interpretable results. Indirect detection using hematological and biochemical parameters can only provide presumptive proof.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
M Audran. 2002. [Methodologies used to screen for doping agents].. https://pubmed.health/record/pubmed%3A12378139/methodologies-used-to-screen-for-doping-agents
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.